About AnalytiCon Discovery
AnalytiCon Discovery is a company based in Potsdam (Germany) founded in 2000 was acquired by BRAIN in July 2014. AnalytiCon Discovery has raised $3.04 million across 4 funding rounds from investors including Brain Biotech, European Union and Berlin Capital Fund. AnalytiCon Discovery offers products and services including Screening Libraries and Discovery Services. AnalytiCon Discovery operates in a competitive market with competitors including C2 Pharma, Magellan BioScience Group, Metagreen, BJ Biochem and Alluvium Biosciences, among others.
- Headquarter Potsdam, Germany
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Brain Biotech Ag
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.04 M (USD)
in 4 rounds
-
Latest Funding Round
$580.54 K (USD), Grant
Jun 01, 2021
-
Investors
Brain Biotech
& 3 more
-
Employee Count
Employee Count
-
Acquired by
BRAIN
(Jul 03, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AnalytiCon Discovery
AnalytiCon Discovery offers a comprehensive portfolio of products and services, including Screening Libraries and Discovery Services.
Offers libraries for natural product screening in drug discovery
Provides development and discovery for pharmaceuticals and cosmetics
People of AnalytiCon Discovery
Unlock access to complete
Unlock access to complete
Funding Insights of AnalytiCon Discovery
AnalytiCon Discovery has successfully raised a total of $3.04M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $580.54 thousand completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $580,543
-
First Round
First Round
(28 Apr 2005)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2021 | Amount | Grant - AnalytiCon Discovery | Valuation |
investors |
|
| Jan, 2018 | Amount | Grant - AnalytiCon Discovery | Valuation |
investors |
|
| May, 2015 | Amount | Grant - AnalytiCon Discovery | Valuation |
investors |
Investors in AnalytiCon Discovery
AnalytiCon Discovery has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Brain Biotech, European Union and Berlin Capital Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Investments are directed by Brandenburg Capital toward multiple sectors.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
Investments & Acquisitions by AnalytiCon Discovery
Financial Statements - AnalytiCon Discovery
Analyticon Discovery Comparisons
Competitors of AnalytiCon Discovery
AnalytiCon Discovery operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as C2 Pharma, Magellan BioScience Group, Metagreen, BJ Biochem and Alluvium Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Manufactures and distributes active pharmaceutical ingredients and compounds worldwide.
|
|
| domain | founded_year | HQ Location |
Identifies and develops microbial natural product leads for pharmaceutical and industrial applications
|
|
| domain | founded_year | HQ Location |
Develops technologies to harness compounds from natural production.
|
|
| domain | founded_year | HQ Location |
Research and development services for sugar derivatives are provided.
|
|
| domain | founded_year | HQ Location |
Specializes as a preclinical CRO, developing high-value small molecules derived from natural sources for clients.
|
Latest news on Analyticon Discovery
Frequently Asked Questions about AnalytiCon Discovery
AnalytiCon Discovery was founded in 2000 and raised its 1st funding round 5 years after it was founded.
AnalytiCon Discovery is headquartered in Potsdam, Germany. It is registered at Potsdam, Brandenburg, Germany.
AnalytiCon Discovery is a funded company, having raised a total of $3.04M across 4 funding rounds to date. The company's 1st funding round was a Grant of $597.55K, raised on Apr 28, 2005.
AnalytiCon Discovery was established in 2000 and is headquartered in Potsdam, Germany. Focus is placed on natural products chemistry within the chemical research sector. Services encompass discovery, isolation, and structural elucidation of compounds from natural sources. Operations are conducted through laboratory-based analysis and collaboration on pharmaceutical and biotech projects. The domain ac-discovery.com serves as the primary online presence for these activities.
AnalytiCon Discovery's top competitors include BJ Biochem, Magellan BioScience Group and Synaco Group.
AnalytiCon Discovery offers Screening Libraries and Discovery Services.
AnalytiCon Discovery has 4 investors. Key investors include Brain Biotech, European Union, Berlin Capital Fund, and Brandenburg Capital.